Valuation : Viatris Inc.

Market Cap 19.35B 16.61B 15.59B 14.24B 26.87B 1,846B 27B 185B 71.51B 931B 72.67B 71.09B 3,084B P/E 2026 *
80x
P/E 2027 * 31.8x
Enterprise Value 31.42B 26.97B 25.31B 23.12B 43.63B 2,997B 43.84B 300B 116B 1,512B 118B 115B 5,007B EV / Sales 2026 *
2.13x
EV / Sales 2027 * 2.02x
Free-Float
91.44%
Yield 2026 *
3.02%
Yield 2027 * 3.1%
1 day+0.78%
1 week+3.72%
Current month-4.04%
1 month-2.26%
3 months+3.63%
6 months+10.49%
Current year+35.34%
1 week 15.98
Extreme 15.98
17.06
1 month 15.88
Extreme 15.88
18.39
Current year 12.19
Extreme 12.19
18.39
1 year 9.42
Extreme 9.425
18.39
3 years 6.85
Extreme 6.85
18.39
5 years 6.85
Extreme 6.85
18.39
10 years 6.85
Extreme 6.85
47.82
Manager TitleAgeSince
Chief Executive Officer 63 01/04/2023
Director of Finance/CFO 59 08/05/2026
Chief Tech/Sci/R&D Officer - 15/12/2023
Director TitleAgeSince
Director/Board Member 78 16/11/2020
Director/Board Member 78 16/11/2020
Director/Board Member 62 16/11/2020
Date Insider Type Main position Quantity % Market Cap.
15/08/26 Fiscal year

Chief Administrative Officer

63,631 0.0054%
30/06/26 Free

Director

2,756 0.0002%
30/06/26 Free

Director

2,362 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+0.78%+3.72%+61.86%+53.60% 19.35B
-3.59%-7.10%+61.60%+114.83% 1,060B
-1.15%-1.25%+52.98%+62.41% 651B
-1.09%-1.15%+26.18%+79.22% 465B
-0.77%-1.75%+39.11%+40.96% 365B
-1.02%-0.30%+23.51%+39.24% 300B
-0.53%+1.03%+2.54%+12.68% 258B
-0.43%-0.46%+52.06%+71.75% 238B
-2.54%+0.19%-16.82%-54.11% 210B
-0.46%+0.33%+29.05%+92.67% 184B
Average -1.08%-0.22%+33.21%+51.33% 374.98B
Weighted average by Cap. -1.73%-2.12%+39.82%+67.45%

Financials

2026 *2027 *
Net sales 14.78B 12.69B 11.91B 10.88B 20.53B 1,410B 20.63B 141B 54.62B 711B 55.5B 54.3B 2,356B 15.03B 12.9B 12.11B 11.06B 20.87B 1,433B 20.97B 143B 55.53B 723B 56.43B 55.2B 2,395B
Net income -27.26M -23.4M -21.96M -20.06M -37.85M -2.6B -38.03M -260M -101M -1.31B -102M -100M -4.34B 340M 292M 274M 250M 472M 32.42B 474M 3.24B 1.26B 16.35B 1.28B 1.25B 54.16B
Net Debt 12.07B 10.36B 9.72B 8.88B 16.75B 1,151B 16.83B 115B 44.58B 581B 45.3B 44.32B 1,923B 11.08B 9.51B 8.93B 8.15B 15.38B 1,057B 15.46B 106B 40.93B 533B 41.6B 40.69B 1,766B
Logo Viatris Inc.
Viatris Inc. is a global healthcare company. The Company markets branded and generic drugs, including complex drugs. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. Its Developed Markets segment comprises its operations primarily in North America and Europe. The Company's Greater China segment includes its operations in mainland China, Taiwan and Hong Kong. The Company's JANZ segment consists of its operations in Japan, Australia and New Zealand. Its Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company's ARV franchise. It produces medicines for patients across a broad range of major therapeutic areas. From cardiovascular health to oncology, it offers treatment options across more than 10 major therapeutic areas covering a variety of noncommunicable and infectious diseases.
Employees
30,000
Date Price Change Volume
26/08/26 $16.85 +0.78% 7,402,327
25/08/26 $16.72 +1.09% 8,331,642
24/08/26 $16.54 +1.35% 4,980,491
21/08/26 $16.32 +1.24% 6,494,519
20/08/26 $16.12 -0.77% 5,329,521
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
16.85USD
Average target price
18.50USD
Spread / Average Target
+9.79%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VTRS Stock